Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
GSK nabs $320M in CureVac patent settlement
The chapter on Pfizer and BioNTech’s mRNA patent feud with CureVac is ending, even as lawsuits over the technology continue to play out elsewhere.
Fraiser Kansteiner
Aug 8, 2025 10:46am
Boehringer's lung cancer med passes muster with the FDA
Aug 8, 2025 3:52pm
CDC unveils campaign targeting teen substance use, mental health
Aug 8, 2025 11:49am
Gilead reports 7% sales decline for CAR-Ts Yescarta, Tecartus
Aug 8, 2025 11:40am
FDA restricts bluebird's gene therapy after blood cancer reports
Aug 8, 2025 11:19am
Sanofi, Trump, VC capital crunch—Fierce Pharma Asia
Aug 8, 2025 9:32am
More News
Is Trump’s MFN pricing order more bark than bite?
Aug 8, 2025 9:18am
Genmab touts new data that set up Epkinly for FL expansion
Aug 8, 2025 7:25am
FDA debuts new program to ease US manufacturing plant setup
Aug 7, 2025 3:16pm
Fierce Healthcare
Drug price negotiation program sidesteps latest legal obstacle
Aug 7, 2025 3:00pm